Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis

BACKGROUND: With an increasing indication spectrum of antiresorptive drugs, the medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy [MRONJ (BP)] is continuously gaining clinical relevance. Impaired osteoclast function, accompanied by altered cell morphology and expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehrhan, Falk, Gross, Christian, Creutzburg, Kay, Amann, Kerstin, Ries, Jutta, Kesting, Marco, Geppert, Carol-Immanuel, Weber, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398259/
https://www.ncbi.nlm.nih.gov/pubmed/30832685
http://dx.doi.org/10.1186/s12967-019-1819-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398259/
https://www.ncbi.nlm.nih.gov/pubmed/30832685
http://dx.doi.org/10.1186/s12967-019-1819-1

Ejemplares similares